AAAAAA

   
Results: 1-14 |
Results: 14
INDOLENT COURSE AS A RELATIVELY FREQUENT PRESENTATION IN T-PROLYMPHOCYTIC LEUKEMIA
Authors: GARAND R GOASGUEN J BRIZARD A BUISINE J CHARPENTIER A CLAISSE JF DUCHAYNE E LAGRANGE M SEGONDS C TROUSSARD X FLANDRIN G
Citation: R. Garand et al., INDOLENT COURSE AS A RELATIVELY FREQUENT PRESENTATION IN T-PROLYMPHOCYTIC LEUKEMIA, British Journal of Haematology, 103(2), 1998, pp. 488-494
ACTIVATED STAT RELATED TRANSCRIPTION FACTORS IN ACUTE-LEUKEMIA
Authors: GOUILLEUXGRUART V DEBIERREGROCKIEGO F GOUILLEUX F CAPIOD JC CLAISSE JF DELOBEL J PRIN L
Citation: V. Gouilleuxgruart et al., ACTIVATED STAT RELATED TRANSCRIPTION FACTORS IN ACUTE-LEUKEMIA, Leukemia & lymphoma, 28(1-2), 1997, pp. 83-88
QUANTIFICATION OF BCL2 PROTEIN EXPRESSION BY FLOW-CYTOMETRY IN B-CHRONIC LYMPHOID LEUKEMIA
Authors: BENATTAR L CAPIOD JC CLAISSE JF CHETAILLE E GOUILLEUX V FUENTES V DESABLENS B DELOBEL J
Citation: L. Benattar et al., QUANTIFICATION OF BCL2 PROTEIN EXPRESSION BY FLOW-CYTOMETRY IN B-CHRONIC LYMPHOID LEUKEMIA, Experimental hematology, 25(8), 1997, pp. 475-475
LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, British Journal of Haematology, 97(1), 1997, pp. 113-118
DEFERRED VERSUS EARLY THERAPY WITH CHLORAMBUCIL IN STAGE A CLL PATIENTS - LONG-TERM RESULTS FROM 2 RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL
Authors: DIGHIERO G CHEVRET S PIGUET H MALOUM K DESABLENS B FENAUX P PIGNON B NAVARRO M LEBLAY R LEPORRIER M JAUBERT J COLOMBAT P VAUGIER G LEPEU G TURPIN F MEFFRE D CLAISSE JF CAZIN B BINET JL CHASTANG C TRAVADE P
Citation: G. Dighiero et al., DEFERRED VERSUS EARLY THERAPY WITH CHLORAMBUCIL IN STAGE A CLL PATIENTS - LONG-TERM RESULTS FROM 2 RANDOMIZED TRIALS OF THE FRENCH COOPERATIVE GROUP IN CLL, Blood, 90(10), 1997, pp. 2572-2572
ROSAI-DORFMAN SINUS HISTIOCYTOSIS IN A PA TIENT WITH HODGKINS-DISEASE- EFFECTIVE TREATMENT WITH ALPHA-INTERFERON
Authors: ALLIOT C CAPIOD JC CLAISSE JF GONTIER MF DESABLENS B
Citation: C. Alliot et al., ROSAI-DORFMAN SINUS HISTIOCYTOSIS IN A PA TIENT WITH HODGKINS-DISEASE- EFFECTIVE TREATMENT WITH ALPHA-INTERFERON, La Presse medicale, 25(4), 1996, pp. 171-171
SCD23, SCD25, LDH OR BETA-2-MICROGLOBULIN - WHAT IS THE BEST PROGNOSTIC FACTOR IN B-CLL
Authors: DESABLENS B CAPIOD JC GOUILLEUX V FUENTES V GARIDI R CLAISSE JF PRIN L
Citation: B. Desablens et al., SCD23, SCD25, LDH OR BETA-2-MICROGLOBULIN - WHAT IS THE BEST PROGNOSTIC FACTOR IN B-CLL, Blood, 88(10), 1996, pp. 960-960
STAT-RELATED TRANSCRIPTION FACTORS ARE CONSTITUTIVELY ACTIVATED IN PERIPHERAL-BLOOD CELLS FROM ACUTE-LEUKEMIA PATIENTS
Authors: GOUILLEUXGRUART V GOUILLEUX F DESAINT C CLAISSE JF CAPIOD JC DELOBEL J WEBERNORDT R DUSANTERFOURT I DREYFUS F GRONER B PRIN L
Citation: V. Gouilleuxgruart et al., STAT-RELATED TRANSCRIPTION FACTORS ARE CONSTITUTIVELY ACTIVATED IN PERIPHERAL-BLOOD CELLS FROM ACUTE-LEUKEMIA PATIENTS, Blood, 87(5), 1996, pp. 1692-1697
EXPRESSION OF P13(MTCPI) IS RESTRICTED TO MATURE T-CELL PROLIFERATIONS WITH T(X-14) TRANSLOCATIONS
Authors: MADANI A CHOUKROUN V SOULIER J CACHEUX V CLAISSE JF VALENSI F DALIPHARD S CAZIN B LEVY V LEBLOND V DANIEL MT SIGAUX F STERN MH
Citation: A. Madani et al., EXPRESSION OF P13(MTCPI) IS RESTRICTED TO MATURE T-CELL PROLIFERATIONS WITH T(X-14) TRANSLOCATIONS, Blood, 87(5), 1996, pp. 1923-1927
TUMOR LYSIS IN CHRONIC LYMPHOID LEUKEMIA TREATED WITH CHLORAMBUCIL AND PREDNISONE
Authors: ALLIOT C CLAISSE JF DESABLENS B
Citation: C. Alliot et al., TUMOR LYSIS IN CHRONIC LYMPHOID LEUKEMIA TREATED WITH CHLORAMBUCIL AND PREDNISONE, La Presse medicale, 24(25), 1995, pp. 1178-1178
SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, Blood, 86(10), 1995, pp. 1377-1377
ALPHA-INTERFERON AND HYPEREOSINOPHILIC SYNDROME WITH TRISOMY-8 - KARYOTYPIC REMISSION
Authors: QUIQUANDON I CLAISSE JF CAPIOD JC DELOBEL J PRIN L
Citation: I. Quiquandon et al., ALPHA-INTERFERON AND HYPEREOSINOPHILIC SYNDROME WITH TRISOMY-8 - KARYOTYPIC REMISSION, Blood, 85(8), 1995, pp. 2284-2285
IS THE CHOP REGIMEN A GOOD TREATMENT FOR ADVANCED CLL - RESULTS FROM 2 RANDOMIZED CLINICAL-TRIALS
Authors: FENAUX P MOREL P BAUTERS F PIGUET H MONCONDUIT M TILLY F DESABLENS B CLAISSE JF ADJIZIAN JC POTRON G PIGNON B LEPORRIER M TROUSSARD X REMAN O BINET JL DIGHIERO G MALOUM K MERLEBERAL H RAPHAEL M REISENLEITER M LINASSIER C LAMAGNERE JP JAUBERT J VASSELOM C LEBLAY R JACOMY D GROSBOIS B DREYFUS B GUILHOT F VAUGIER G SOUTEYRAND P LEPEU G TOUCHAIS AM BOUDJERRA N BORDESSOULE M SCHMIDT J FACQUETDANIS J SEBBAN C ALLARD C MURGUE B SCHVED JF ARNAUD A CASSASSUS P LEPRISE PY DOR JF TURPIN F SOLALCELIGNY P TERTIAN G BERNARD JF JAMES JM REIGNER A BLANC M RAPP MJ BOURGEOIS JP LEJEUNE F SALLES B RENOUX M GARIN B CAMO J TCHERNIA G CECCALDI J DEVIDAS A LEMEVELLEPOURHIET A BRIERE J JANVIER M NAJEAN Y CHEVRET S CHASTANG C TRAVADE P
Citation: P. Fenaux et al., IS THE CHOP REGIMEN A GOOD TREATMENT FOR ADVANCED CLL - RESULTS FROM 2 RANDOMIZED CLINICAL-TRIALS, Leukemia & lymphoma, 13(5-6), 1994, pp. 449-456
TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BINET JL FENAUX P MOREL P BAUTERS F PIGUET H MONCONDUIT M TILLY F DESABLENS B CLAISSE JF ADJIZIAN JC POTRON G PIGNON B LEPORRIER M TROUSSARD X REMAN O BINET JL MALOUM K MERLEBERAL H RAPHAEL M REISENLEITER M LINASSIER C LAMAGNERE JP JAUBERT J VASSELOM C LEBLAY R JACOMY D GROSBOIS B DREYFUS B GUILHOT F VAUGIER G SOUTEYRAND P LEPEU G TOUCHIAS AM BOUDJERRA N BORDESSOULE M TRAVADE P SCHMIDT J FACQUETDANIS J SEBBAN C ALLARD C ROUSSET T NAVARRO M SCHVED JF ARNAUD A CASASSUS P LEPRISE PY DOR JF TURPIN F SOLALCELIGNY P TERTIAN G BERNARD JF JAMES JM REIGNER A BLANC M RAPP MJ BOURGEOIS JP LEJEUNE F SALLES B RENOUX M GARIN B CAMP J TCHERNIA G CECCALDI J DEVIDAS A LEMEVELLEPOURHIET A BRIERE J JANVIER M NAJEAN Y KERNEIS Y COIFFIE B DIGHIERO G TEILLET F",GARNIER,DOIRON,STOPPA,ROGE,"MAIGRE M",MAISONNEUVE,"DIVINE M",CHERON,RODON,SIMON,THYSS,"BRION A",EGHBALI,CHRISTIAN,CARDE,AUTRAND,PAITEL,"SELIGMANN M",VIGNERON
Citation: Jl. Binet et al., TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA, Bailliere's clinical haematology, 6(4), 1993, pp. 867-878
Risultati: 1-14 |